Marshall Wace
IPXL

Marshall Wace’s Impax Laboratories, Inc. IPXL Stock Holding History

Marshall Wace’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,729
Closed -$252K – 1242
2016
Q2 		$252K Sell
8,729
-47,361
-84% -$1.54M ﹤0.01% 916
2016
Q1 		$1.8M Sell
56,090
-20,534
-27% -$722K 0.02% 582
2015
Q4 		$3.28M Buy
+76,624
New +$3.06M 0.03% 470
2015
Q2 		– Sell
-6,270
Closed -$294K – 1130
2015
Q1 		$294K Buy
+6,270
New +$249K ﹤0.01% 723
2014
Q3 		– Sell
-242,396
Closed -$7.27M – 1138
2014
Q2 		$7.27M Buy
+242,396
New +$6.54M 0.11% 221

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's IPXL Position: Q3 2016 in Review

Marshall Wace sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 8,729 shares — an estimated $252K sold.

Marshall Wace first reported a position in IPXL in Q2 2014 and held it in 5 quarters. The position peaked at $7.27M in Q2 2014. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Marshall Wace reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Marshall Wace sold 8,729 Impax Laboratories, Inc. shares in Q3 2016, an estimated $252K.
  • Marshall Wace first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 5 quarters.
  • Marshall Wace's Impax Laboratories, Inc. position peaked at $7.27M in Q2 2014.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.